Skip to main navigation Skip to search Skip to main content

Phase 1 Study of Tru-016, An Anti-CD37 SMIP™ Protein in Naïve and Relapsed and/or Refractory CLL Patients

  • Farrukh T Awan
  • , John M. Pagel
  • , Leslie A Andritsos
  • , Ajay K. Gopal
  • , Richard R. Furman
  • , Stephen Spurgeon
  • , Delva Deauna-Limayo
  • , Scott Stromatt
  • , John C. Byrd

    Research output: Contribution to journal › Article › peer-review

    Original languageAmerican English
    JournalBlood
    Volume118
    StatePublished - Nov 18 2011

    Disciplines

    • Medicine and Health Sciences
    • Immunology and Infectious Disease

    Cite this